Sera Prognostics, Inc. Stock Analysis & AI Score
Sera Prognostics, Inc. (SERA) has an ST Score of 46.9 (C+), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $6.00 price target (+184.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Sera Prognostics, Inc. (SERA) has an ST Score of 46.9 (C+), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $6.00 price target (+184.4% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- ValuationB+
- Financial StrengthB+
- GrowthC+
- MomentumD
- ProfitabilityF
- Piotroski3/9
Contact
SERA stock: frequently asked questions
What is SERA's ST Score?
Sera Prognostics, Inc. (SERA) has an ST Score of 46.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SERA a buy, hold, or sell?
Analysts rate SERA a Buy, with a price target of $6.00 (+184.4% vs the current price). Our ST Score grades it C+ (46.9/100). The ST Score is a data-driven signal, not a recommendation.
What are SERA's factor grades?
Valuation B+, Profitability F, Financial Strength B+, Momentum D, Growth C+, Forecast A.
What is SERA's valuation grade?
Sera Prognostics, Inc. (SERA) earns a valuation grade of B+, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SERA's growth grade?
Sera Prognostics, Inc. (SERA) earns a growth grade of C+, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SERA's profitability grade?
Sera Prognostics, Inc. (SERA) earns a profitability grade of F, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SERA's financial strength grade?
Sera Prognostics, Inc. (SERA) earns a financial strength grade of B+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SERA?
The average analyst price target for Sera Prognostics, Inc. (SERA) is $6.00 from 5 analysts, which is +184.4% versus the recent price of $2.11.
What is SERA's Piotroski score?
Sera Prognostics, Inc. (SERA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.